Ibaraki, Japan

Takahisa Hanada

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Ibaraki, JP (2004 - 2009)
  • Tsukuba, JP (2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takahisa Hanada: Innovator in Pharmaceutical Chemistry

Introduction

Takahisa Hanada is a notable inventor based in Ibaraki, Japan, recognized for his contributions to pharmaceutical chemistry. He holds a total of four patents, showcasing his innovative approach to drug development and therapeutic solutions.

Latest Patents

Among his latest patents, Hanada has developed novel indansulfamide derivatives, which include compounds such as N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-inden-1-yl]sulfamide. These compounds have demonstrated an ability to improve the Seizure Severity Index in mice kindling models, indicating their potential as drugs for treating epilepsy. Additionally, he has created 1,2-dihydropyridine compounds that exhibit excellent AMPA receptor inhibitory action, further contributing to advancements in the field of neuropharmacology.

Career Highlights

Takahisa Hanada has worked with prominent companies in the pharmaceutical industry, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work in these organizations has allowed him to focus on innovative drug development and research.

Collaborations

Throughout his career, Hanada has collaborated with esteemed colleagues such as Satoshi Nagato and Kohshi Ueno. These partnerships have facilitated the exchange of ideas and expertise, enhancing the impact of his research.

Conclusion

Takahisa Hanada's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new therapeutic options in treating neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…